A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study

被引：0
|
作者：
Martin H. Stradner
Christian Dejaco
Kerstin Brickmann
Winfried B. Graninger
Hans Peter Brezinschek
机构：
[1] Medical University of Graz,Division of Rheumatology and Immunology
来源：
Arthritis Research & Therapy | / 18卷
关键词：
Rheumatoid arthritis; Biomarker; Rituximab; T cells; Plasmablasts; Lymphocytes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis
    Genovese, Mark C.
    Cohen, Stanley B.
    Wofsy, David
    Weinblatt, Michael E.
    Firestein, Gary S.
    Brahn, Ernest
    Strand, Vibeke
    Baker, Daniel G.
    Tong, Sandra E.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (05) : 846 - 854
  • [42] Six and 12 Weeks Treatment Response Predicts Continuation of Tumor Necrosis Factor Blockade in Rheumatoid Arthritis: An Observational Cohort Study from Southern Sweden
    Gulfe, Anders
    Kristensen, Lars Erik
    Geborek, Pierre
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (03) : 517 - 521
  • [43] Efficacy and safety of a combination therapy of methotrexate, chloroquine and cyclophosphamide in patients with refractory rheumatoid arthritis: Results of an observational study with matched-pair analysis
    Keyszer, G
    Keysser, C
    Keysser, M
    CLINICAL RHEUMATOLOGY, 1999, 18 (02) : 145 - 151
  • [44] Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study
    Venerito, Vincenzo
    Stefanizzi, Pasquale
    Cantarini, Luca
    Lavista, Marlea
    Galeone, Maria Grazia
    Di Lorenzo, Antonio
    Iannone, Florenzo
    Tafuri, Silvio
    Lopalco, Giuseppe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [45] Switching from TNFα inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFα inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trial
    Jung, Sang Youn
    Koh, Jung Hee
    Kim, Ki-Jo
    Park, Yong-Wook
    Yang, Hyung-In
    Choi, Sung Jae
    Lee, Jisoo
    Choi, Chan-Bum
    Kim, Wan-Uk
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [46] Switching from TNFα inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFα inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trial
    Sang Youn Jung
    Jung Hee Koh
    Ki-Jo Kim
    Yong-Wook Park
    Hyung-In Yang
    Sung Jae Choi
    Jisoo Lee
    Chan-Bum Choi
    Wan-Uk Kim
    Arthritis Research & Therapy, 23
  • [47] Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study
    Strand, V
    van der Heijde, D.
    Tanaka, Y.
    Keystone, E.
    Kremer, J.
    Zerbini, C. A. F.
    Cardiel, M. H.
    Cohen, S.
    Nash, P.
    Song, Y-W
    Tegzova, D.
    Gruben, D.
    Wallenstein, G.
    Connell, C. A.
    Fleischmann, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (05) : 848 - 857
  • [48] B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients
    Jens Thiel
    Marta Rizzi
    Marie Engesser
    Ann-Kathrin Dufner
    Arianna Troilo
    Raquel Lorenzetti
    Reinhard E. Voll
    Nils Venhoff
    Arthritis Research & Therapy, 19
  • [49] B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients
    Thiel, Jens
    Rizzi, Marta
    Engesser, Marie
    Dufner, Ann-Kathrin
    Troilo, Arianna
    Lorenzetti, Raquel
    Voll, Reinhard E.
    Venhoff, Nils
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [50] Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNF alpha drugs: results from the observational retrospective-prospective RUBINO study
    Bazzichi, L.
    Biasi, D.
    Tinazzi, E.
    Muratore, M.
    Pellerito, R.
    Russo, R.
    Santi, M. Corsaro
    De Sandre, P.
    Epis, O.
    Granata, M.
    Kroegler, B.
    Meschini, C.
    Versace, F.
    Astolfi, C.
    REUMATISMO, 2014, 66 (03) : 224 - 232
12345